The sales of anxiolytic medicine in Austria are projected to decline steadily from 7.0 million USD in 2024 to 6.5 million USD by 2028. This indicates a negative trend in the market with a consistent year-on-year reduction. For context, the market for anxiolytic medicines stood at 7.1 million USD in 2023, suggesting a slight downward trend that began even before the forecasted years.
- Year-on-year percentage variations are as follows: 2025 (-1.4%), 2026 (-1.4%), 2027 (-2.9%), 2028 (-1.5%).
- The compound annual growth rate (CAGR) from 2023 to 2028 is -1.8%, demonstrating a gradual decrease over the five-year period.
Future trends to watch for include potential market impacts of new anxiolytic drugs entering the market, shifts in mental health awareness and treatment methods, and regulatory changes that could affect prescription rates. Additionally, an increase in alternative therapies and digital health solutions may further influence the demand for anxiolytic medicines.
